Alpine Immune Sciences, Inc. (ALPN)
NASDAQ: ALPN · IEX Real-Time Price · USD
64.60
0.00 (0.00%)
At close: May 2, 2024, 4:00 PM
64.56
-0.04 (-0.06%)
After-hours: May 2, 2024, 7:10 PM EDT
Alpine Immune Sciences Employees
Alpine Immune Sciences had 142 employees on December 31, 2023. The number of employees increased by 16 or 12.70% compared to the previous year.
Employees
142
Change (1Y)
16
Growth (1Y)
12.70%
Revenue / Employee
$414,620
Profits / Employee
-$226,648
Market Cap
4.24B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 142 | 16 | 12.70% |
Dec 31, 2022 | 126 | 41 | 48.24% |
Dec 31, 2021 | 85 | 28 | 49.12% |
Dec 31, 2020 | 57 | 4 | 7.55% |
Dec 31, 2019 | 53 | 5 | 10.42% |
Dec 31, 2018 | 48 | 10 | 26.32% |
Dec 31, 2017 | 38 | 23 | 153.33% |
Dec 31, 2016 | 15 | -16 | -51.61% |
Dec 31, 2015 | 31 | 6 | 24.00% |
Dec 31, 2014 | 25 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Perrigo Company | 9,140 |
Merit Medical Systems | 6,950 |
Alkermes | 2,100 |
Alvotech | 1,026 |
Doximity | 977 |
Insmed | 912 |
TransMedics Group | 584 |
Madrigal Pharmaceuticals | 376 |
ALPN News
- 6 days ago - ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN - Business Wire
- 15 days ago - INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN - PRNewsWire
- 21 days ago - Vertex Pharmaceuticals to Buy Alpine Immune in $4.9B Deal - Barrons
- 21 days ago - Vertex may have to pay more than $65 for Alpine Immune stock ($ALPN) - Invezz
- 21 days ago - Vertex Pharma's $4.9 billion takeover of Alpine Immune expected to boost its rare-disease portfolio - Market Watch
- 22 days ago - Vertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B—Key Level to Watch - Investopedia
- 22 days ago - Shareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertex - PRNewsWire
- 22 days ago - Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal - GeekWire